Atrovent 250 Mcg Vials

Atrovent 250 Mcg Vials

Description:

Atrovent 250 mcg/2 ml unit dose vials is a prescription bronchodilator medicine containing ipratropium bromide, an anticholinergic (muscarinic antagonist) used for inhalation via nebulizer. It is indicated for the maintenance and relief of bronchospasm associated with chronic obstructive pulmonary disease (copd), including chronic bronchitis and emphysema, and may be used as part of asthma management as directed by a physician. Atrovent works locally in the airways to relax bronchial smooth muscle, improve airflow, and reduce breathing difficulties without significantly affecting respiratory secretions.

Indications:

• Maintenance treatment of bronchospasm associated with chronic obstructive pulmonary disease (copd).
• Chronic bronchitis with reversible bronchospasm.
• Emphysema with associated airflow limitation.
• Adjunctive treatment of acute and chronic bronchospasm in asthma, as prescribed by a doctor.
• Symptomatic relief of wheezing, chest tightness, and shortness of breath due to obstructive airway disease.

Active Ingredients / Key Components:

• Ipratropium bromide – 250 mcg per 2 ml unit dose vial (anticholinergic bronchodilator).
• Excipients (such as sodium chloride, purified water and stabilizers) – exact composition and concentrations are not specified in the available information (For full ingredient information, please check the product leaflet or the manufacturer’s official website.); please refer to the official package insert for full excipient list.

Dosage & Administration / How to Use:

• This medicine is for inhalation via nebulizer only. Do not inject or swallow.
• Usual adult dose for copd (as commonly referenced): 1 unit dose vial (250 mcg/2 ml) inhaled via nebulizer 3–4 times daily, or as directed by the treating physician. Exact dosing regimen must be individualized by a doctor.
• For elderly patients or those with comorbidities, dosing and frequency should be strictly according to medical advice.
• Children: use only if prescribed by a pediatrician; dose and frequency depend on age, weight, and clinical condition.
• How to use with nebulizer:
  • 1. Wash hands thoroughly before handling the vial and nebulizer.
  • 2. Open one unit dose vial by twisting off the top.
  • 3. Squeeze the full contents (2 ml) into the nebulizer chamber. Dilution with normal saline may be recommended by your doctor if needed.
  • 4. Assemble the nebulizer according to the manufacturer’s instructions and connect to the compressor.
  • 5. Place the mouthpiece in the mouth (or mask over nose and mouth) and breathe in slowly and deeply until the mist stops (usually 5–15 minutes).
  • 6. Clean and dry the nebulizer parts after each use as per device instructions.
• Can be used with or without food, as it acts locally in the lungs.
• Do not exceed the prescribed dose or frequency. If a dose is missed, take it as soon as you remember unless it is almost time for the next dose. Do not double the dose.

Clinical Benefits:

• Provides effective bronchodilation by relaxing bronchial smooth muscle and widening the airways.
• Helps relieve symptoms of copd such as wheezing, chest tightness, and shortness of breath.
• Acts locally in the lungs with minimal systemic absorption, reducing the risk of systemic side effects compared with some oral bronchodilators.
• Does not significantly alter the volume or consistency of respiratory secretions and does not depress mucociliary clearance.
• Can be combined with beta-2 agonist bronchodilators (such as salbutamol) in nebulizer therapy when prescribed, for enhanced bronchodilation.

Warnings & Contraindications:

• Use only under medical supervision. This is a prescription medicine.
• Contraindicated in patients with known hypersensitivity to ipratropium bromide, atropine or its derivatives, or any component of the formulation.
• Use with caution in patients with narrow-angle glaucoma, prostatic hyperplasia, bladder neck obstruction, or other conditions where anticholinergic effects may worsen symptoms.
• Avoid contact of the nebulized solution or mist with the eyes; accidental eye exposure may cause eye pain, blurred vision, or precipitate acute narrow-angle glaucoma in susceptible individuals.
• If sudden worsening of breathing, increased wheezing, or lack of response occurs, seek immediate medical attention; do not increase the dose on your own.
• Consult your doctor before use if pregnant or planning pregnancy; use only if the potential benefit justifies the potential risk.
• Consult your doctor before use if breastfeeding; it is not known to what extent ipratropium bromide passes into breast milk.
• Inform your doctor about all medications you are taking, especially other inhaled bronchodilators, anticholinergic drugs, or medications for glaucoma, prostate problems, or urinary retention.
• Patients with cystic fibrosis may be more prone to gastrointestinal motility disturbances when using anticholinergic agents.
• Not intended to diagnose, treat, cure, or prevent any disease without proper medical supervision.
• Keep out of reach of children.

Side Effects:

• Common side effects may include dry mouth, throat irritation, cough, mild headache, nausea, or dizziness.
• Less common side effects can include palpitations, tachycardia, difficulty urinating, constipation, or gastrointestinal discomfort.
• Eye-related effects (usually due to accidental eye exposure) may include blurred vision, eye pain, red eyes, or seeing halos; these may indicate acute narrow-angle glaucoma and require urgent medical attention.
• Allergic reactions are rare but serious: symptoms may include rash, itching, swelling of the face, lips or tongue, severe dizziness, or difficulty breathing. Stop use and seek emergency medical help immediately if these occur.
• If any side effect is severe, persistent, or worrying, contact your doctor or pharmacist promptly.

Storage Instructions:

Store in a cool, dry place away from direct sunlight and heat sources. Do not freeze. Keep the unit dose vials in the original foil pouch until use to protect from light and contamination. Do not use after the expiry date printed on the pack. Keep container tightly closed and keep out of reach of children.

Specifications:

• Form: Inhalation solution for nebulization.
• Strength: 250 mcg ipratropium bromide per 2 ml unit dose vial.
• Pack size: 20 unit dose vials (2 ml each) – total 40 ml solution.
• Route of administration: Inhalation via nebulizer.

Disclaimer:
All pharmacy products are intended for general use only and do not replace professional medical advice, diagnosis, or treatment. Always consult a healthcare provider before use. Results may vary, and no specific outcomes are guaranteed. Products are not intended to diagnose, treat, cure, or prevent any disease unless stated. Follow label instructions carefully, as misuse may cause adverse effects. Compliance with local laws is the customer’s responsibility.